Jenna Richardson
Acute Care · Memphis, TNNPI 1841875911
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,356 of the $6,329 with a category attached, or 84.6%. 27 manufacturers reported payments, led by Enterra Medical, Inc. at 24.0% of the total. 2025 is the largest year on record at $5,342, more than ten times the $178 reported in 2021. Among acute care clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $44.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Enterra Medical, Inc.$2K
- AbbVie$711
- Abiomed$550
- Madrigal Pharmaceuticals$441
- Ardelyx, Inc.$394
- Phathom Pharmaceuticals, Inc.$358
- plus $2K from 21 others
What the payments were for
- Travel & lodging$97315%
- Food & beverage$5,35685%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Enterra Medical, Inc. | 7 | $1,520 |
| AbbVie | 32 | $711 |
| Abiomed | 8 | $550 |
| Madrigal Pharmaceuticals | 9 | $441 |
| Ardelyx, Inc. | 10 | $394 |
| Phathom Pharmaceuticals, Inc. | 4 | $358 |
| Lilly USA, LLC | 8 | $322 |
| Johnson & Johnson | 5 | $285 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $269 |
| Novartis | 11 | $204 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $198 |
| Gilead | 5 | $167 |
| Sanofi | 3 | $166 |
| Pulmonx Corporation | 1 | $147 |
| Pfizer | 2 | $104 |
| United Therapeutics Corporation | 1 | $100 |
| Aimmune Therapeutics, Inc. | 5 | $88 |
| Actelion Pharmaceuticals US, Inc. | 4 | $52 |
| AstraZeneca | 3 | $49 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $46 |
| Novo Nordisk | 2 | $39 |
| Haemonetics Corporation | 1 | $28 |
| Ambu Inc. | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Merck | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Evoke Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$351
- Impella$282
- REZDIFFRA$271
- IBSRELA$250
- Tremfya$230
- LINZESS$228
- CHARTIS CATHETER$147
- ZEPHYR DELIVERY CATHETER$147
- ZEPHYR ENDOBRONCHIAL VALVE$147
- PULMONX CHARTIS TABLET CONSOLE$147
- DUPIXENT$122
- Epclusa$122
- ZEPBOUND$120
- Mavyret$119
- XIFAXAN$118
- Entyvio$113
How this compares
$6,329 in reported general payments places this provider in the 90th percentile of 738 acute care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Memphis
- Anne AlexandrovMemphis$110K
- Errol HookMemphis$8K
- Lindsey CroweMemphis$7K
- Lauren PlylerMemphis$7K
- Jennifer OdellMemphis$7K
- Haley HoyNashville$368K
- Stephen MillerKnoxville$108K
- Shannon GraceNashville$57K
- Timothy BallardKnoxville$47K
- Kelsey MartinNashville$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.